Table 3.
Laboratory and echocardiography findings.
| Total | EHRA I | EHRA > I | p | |
|---|---|---|---|---|
| Laboratory data, mean (SD) | ||||
| Hemoglobin, g/dL | 13.18 (1.96) | 13.15 (0.50) | 13.21 (0.50) | 0.67 |
| Creatinine, mg/dL | 1.259 (0.74) | 1.09 (0.9–1.38) | 1.10 (0.9–1.4) | 0.03 |
| Total cholesterol, mg/dL * | 162 (52) | 155 (50) | 168 (53) | <0.0001 |
| Echocardiography data, median (IQR) | ||||
| LVEF, % | 54 (40–60) | 55 (40–60) | 52 (40–60) | 0.001 |
| LA, mm * | 47 (42–51) | 48 (43–53) | 46 (42–50) | <0.0001 |
| LA area, cm square * | 29.0 (25.0–35.0) | 29.1 (25.0–34.9) | 29.0 (25.0–35.0) | 0.54 |
| LVDd, mm * | 52 (47–58) | 53 (48–58) | 51 (47–57) | <0.0001 |
Abbreviations: LA, left atrium antero-posterior dimension; LVDd, left ventricular end-diastolic dimension; LVEF, left ventricular ejection fraction; EHRA, European Heart Rhythm Association score. * data available in < 80% of patients.